A randomized study comparing methylprednisolone plus chlorambucil versus methylprednisolone plus cyclophosphamide in idiopathic membranous nephropathy

Journal of the American Society of Nephrology

Volumn 9, Issue 3, 1998, Pages 444-450

  Ponticelli, Claudio ^a   Altieri, Paolo ^b   Scolari, Francesco ^c   Passerini, Patrizia ^a   Roccatello, Dario ^d   Cesana, Bruno ^a   Melis, Patrizia ^b   Valzorio, Brunella ^c   Sasdelli, Mauro ^e   Pasquali, Sonia ^f   Pozzi, Claudio ^g   Piccoli, Giuseppe ^d   Lupo, Antonio ^h   Segagni, Siro ⁱ   Antonucci, Francesco ^j   Dugo, Mauro ^k   Minari, Marilena ^l   Scalia, Alfio ^m   Pedrini, Luciano ⁿ   Pisano, Gabriele ^o   Grassi, Claudio ^p   Farina, Marco ^q   Bellazzi, Roberto ^r   more..

^a FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^b BROTZU HOSPITAL   (Italy)

^c SPEDALI CIVILI   (Italy)

^d S GIOVANNI BOSCO HOSPITAL   (Italy)

^e Ospedale Civile   (Italy)

^f Ospedale Malpighi   (Italy)

^g Lecco   (Italy)

^h Ospedale Civile Maggiore   (Italy)

ⁱ Fondazione Clinica del Lavoro   (Italy)

^j Ospedale Provinciale   (Italy)

^k Ospedale Provinciale   (Italy)

^l Ospedale Regionale   (Italy)

^m Ospedale Zonale Uboldo Cernusco   (Italy)

ⁿ Ospedale Provinciale Civile   (Italy)

^o Ospedale Provinciale   (Italy)

^p Ospedale Predabissi   (Italy)

^q Ospedale Provinciale Maggiore   (Italy)

^r Ospedale Provinciale Civile   (Italy)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CHLORAMBUCIL; CYCLOPHOSPHAMIDE; METHYLPREDNISOLONE;

ADOLESCENT; ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEMBRANOUS GLOMERULONEPHRITIS; MULTICENTER STUDY; NAUSEA; NEPHROTIC SYNDROME; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; VOMITING;

EID: 0031890912     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Ponticelli C, Zucchelli P, Imbasciati E, Cagnoli L, Pozzi C, Passerini P, Grassi C, Limido D, Pasquali S, Volpini T, Sasdelli M, Locatelli F: Controlled trial of methylprednisolone and chlorambucil in idiopathic membranous nephropathy. N Engl J Med 310: 945-950, 1984
2. Ponticelli C, Zucchelli P, Passerini P, Cagnoli L, Cesana B, Pozzi C, Pasquali S, Imbasciati E, Grassi C, Redaelli B, Sasdelli M, Locatelli F: A randomized trial of methylprednisolone and chlorambucil in idiopathic membranous nephropathy. N Engl J Med 320: 8-13, 1989
3. Ponticelli C, Zucchelli P, Passerini P, Cesana B, and the Italian Idiopathic Membranous Nephropathy Treatment Study Group: Methylprednisolone plus chlorambucil as compared with methylprednisolone alone for the treatment of idiopathic membranous nephropathy. N Engl J Med 327: 599-603, 1992
4. Ponticelli C, Zucchelli P, Passerini P, Cesana B, Locatelli F, Pasquali S, Sasdelli M, Redaelli B, Grassi C, Pozzi C, Bizzarri D, Banfi G: A 10-year follow-up of a randomized study with methylprednisolone and chlorambucil in membranous nephropathy. Kidney Int 48: 1600-1604, 1995
5. Reichert LJ, Huysmans FTM, Assman K, Koene RAP, Wetzels JFM: Preserving renal function in patients with membranous nephropathy: Daily oral chlorambucil compared with intermittent monthly pulses of cyclophosphamide. Ann Intern Med 121: 328-333, 1994
6. Brunkhorst R, Wrenger E, Koch KM: Low-dose prednisolone/ chlorambucil therapy in patients with severe membranous glomerulonephritis. Clin Invest 72: 277-280, 1994
7. Mathieson PW, Turner AN, Maidment CGH, Evans DJ, Rees AJ: Prednisolone and chlorambucil treatment in idiopathic membranous nephropathy with deteriorating renal function. Lancet 2: 869-872, 1988
8. Ehrenreich T, Churg J: Pathology of membranous nephropathy. In: Pathology Annual, edited by Sommers SC, New York, Appleton-Century-Crofts, 1986, pp 145-186
9. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53: 457-481, 1958
10. Kirk RE: Experimental Design: Procedures for the Behavioral Sciences, 2nd Ed., Monterey, CA, Brooks-Cole, 1982, pp 489-505
11. Geisser S, Greenhouse SW: An extension of Box's results on the use of the F distribution in multivariate analysis. Ann Math Stat 29: 885-891, 1958
12. Ordonez JD, Hiatt RA, Killebrew EJ, Fireman BH: The increased risk of coronary heart disease associated with nephrotic syndrome. Kidney Int 44: 638-642, 1993
13. Bellomo R, Atkins RC: Membranous nephropathy and thromboembolism: Is prophylactic anticoagulation warranted? Nephron 63: 249-253, 1993
14. Sarasin FP, Schifferli JA: Prophylactic oral anticoagulation in nephrotic patients with idiopathic membranous nephropathy. Kidney Int 45: 578-585, 1994
15. Remuzzi G, Bertani T: Is glomerulosclerosis a consequence of altered glomerular permeability to macromolecules? Kidney Int 38: 384-394, 1990
16. Burton C, Harris KPG: The role of proteinuria in the progression of chronic renal failure. Am J Kidney Dis 6: 765-771, 1996
17. Davison AM, Cameron JS, Kerr DN, Ogg CS, Wilkinson RW: The natural history of renal function in untreated idiopathic membranous glomerulonephritis in adults. Clin Nephrol 22: 61-67, 1984
18. Passerini P, Pasquali S, Cesana B, Zucchelli P, Ponticelli C: Long-term outcome of patients with membranous nephropathy after complete remission of proteinuria. Nephrol Dial Transplant 4: 525-529, 1989
19. Ponticelli C, Passerini P, Altieri P, Locatelli F, Pappalettera M: Remissions and relapses in idiopathic membranous nephropathy. Nephrol Dial Transplant 7[Suppl 1]: 85-90, 1992
20. Berk PD, Goldberg JD, Silverstein MN, Weinfeld A, Donovan PB, Ellis JT, Landaw SA, Laszlo J, Najean Y: Increased incidence of acute leukemia in polycythemia vera associated with chlorambucil therapy. N Engl J Med 304: 441-447, 1981
21. Kahn MF, Arlet J, Bloch-Michel H, Caroit M, Chaouat Y, Renier JC: Leucémies aiguës après traitement par agents cytotoxiques en rheumatologie: 19 observations chez 2006 patients. Nouv Presse Med 8: 1393-1397, 1979
22. Wall RL, Clausen KP: Carcinoma of the urinary bladder in patients receiving cyclophosphamide. N Engl J Med 293: 271-273, 1975
23. Kinlen LJ, Sheil AGR, Peto J, Doll R: Collaborative United Kingdom-Australasian study of cancer in patients treated with immunosuppressive drugs. Br Med J 2: 1461-1466, 1979
24. Smith AG, Prentice AG, Lucie NP, Browning JD, Dagg JH, Rowan RM: Acute myelogenous leukemia following cytotoxic therapy: Five cases and a review. Q J Med 51: 227-240, 1982
25. Grunwald HW, Rosner F: Acute leukemia and immunosuppressive drug use. Arch Intern Med 139: 461-466, 1979
26. Baltus JAM, Boersma JW, Hartman AP, Vandenbroucke JP: The occurrence of malignancies in patients with rheumatoid arthritis treated with cyclophosphamide: A controlled retrospective follow-up. Ann Rheum Dis 42: 368-373, 1983
27. Alpers CE, Cotran RS: Neoplasia and glomerular injury. Kidney Int 30: 465-473, 1986
28. Burstein DM, Korbet SM, Schwartz MM: Membranous glomerulonephritis and malignancy. Am J Kidney Dis 22: 5-10, 1993
29. Fraumeni JF, Devasa SS, Hoover RN, Kinlen LJ: Epidemiology of cancer. In: Cancer Principles 38 Practice of Ontology, 4th Ed., edited by Devita VT, Hellman S, Rosenberg SA, Philadelphia, J. B. Lippincott, 1993, pp 150-181